These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 32719810)

  • 21. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients.
    Wang H; Yan D; Li Y; Gong Y; Mai Y; Li B; Zhu X; Wan X; Xie L; Jiang H; Zhang M; Sun M; Yao Y; Zhu Y
    Infect Dis Poverty; 2022 Feb; 11(1):15. PubMed ID: 35109926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19.
    Rezaeian S; Razmjooei F; Pourmokhtari M; Abdoli A; Mofazzal Jahromi MA; Bagheri K
    Heliyon; 2023 Dec; 9(12):e22896. PubMed ID: 38076059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study.
    Zeng ZY; Feng SD; Chen GP; Wu JN
    BMC Infect Dis; 2021 Jan; 21(1):80. PubMed ID: 33461497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
    Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
    Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Hematological Parameters in the Grading of COVID-19 and a Model to Predict the Outcome in Inpatients.
    Kumar Y; Kumari A; Kumar T; Jha K; Zabihullah M
    Cureus; 2023 Sep; 15(9):e45276. PubMed ID: 37846240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil Lymphocyte Ratio as a Marker of In-Hospital Deterioration in COVID-19: Observations From a Resource Constraint Setting.
    Perera N; de Silva A; Kumbukage M; Rambukwella R; Indrakumar J
    Clin Pathol; 2022; 15():2632010X221090898. PubMed ID: 35450133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies.
    Yousefi Z; Taheri N; Dargahi M; Chaman R; Binesh E; Emamian MH; Jafari R
    Curr Microbiol; 2022 Feb; 79(4):96. PubMed ID: 35150319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study.
    Noor A; Akhtar F; Tashfeen S; Anwar N; Saleem B; Khan SA; Akram Z; Shahid S
    J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S595-S601. PubMed ID: 33754514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.
    Servian CDP; Spadafora-Ferreira M; Dos Anjos DCC; Guilarde AO; Gomes-Junior AR; Borges MASB; Masson LC; Silva JMM; de Lima MHA; Moraes BGN; Souza SM; Xavier LE; de Oliveira DCA; Batalha-Carvalho JV; Moro AM; Bocca AL; Pfrimer IAH; Costa NL; Feres VCR; Fiaccadori FS; Souza M; Gardinassi LG; Durigon EL; Romão PRT; Jorge SAC; Coelho V; Botosso VF; Fonseca SG
    Front Immunol; 2023; 14():1206979. PubMed ID: 37876932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics.
    Padoan A; Cosma C; Sciacovelli L; Faggian D; Plebani M
    Clin Chem Lab Med; 2020 Jun; 58(7):1081-1088. PubMed ID: 32301749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio and Their Role as Predictors of Disease Severity of Coronavirus Disease 2019 (COVID-19).
    Jain R; Gopal A; Pathak BK; Mohakuda SS; Tilak T; Singh AR
    J Lab Physicians; 2021 Mar; 13(1):58-63. PubMed ID: 34103879
    [No Abstract]   [Full Text] [Related]  

  • 36. Routine hematology parameters in COVID-19: A predictor of disease severity and mortality.
    Awale RB; Singh A; Mishra P; Bais PS; Vansh K; Shamim R; Ghatak T; Hashim Z; Gupta D; Nath A; Singh RK; Singh C; Pande S
    J Family Med Prim Care; 2022 Jul; 11(7):3423-3429. PubMed ID: 36387722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Lynch KL; Whitman JD; Lacanienta NP; Beckerdite EW; Kastner SA; Shy BR; Goldgof GM; Levine AG; Bapat SP; Stramer SL; Esensten JH; Hightower AW; Bern C; Wu AHB
    Clin Infect Dis; 2021 Jan; 72(2):301-308. PubMed ID: 33501951
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.